Fibroadenoma risk factors: Difference between revisions

Jump to navigation Jump to search
(Mahshid)
Line 5: Line 5:
Common risk factors in the development of fibroadenoma are [[obesity]], [[eostrogen replacement therapy]], and [[pregnancy|nulliparity]].<ref name="pmid9754521">{{cite journal| author=Greenberg R, Skornick Y, Kaplan O| title=Management of breast fibroadenomas. | journal=J Gen Intern Med | year= 1998 | volume= 13 | issue= 9 | pages= 640-5 | pmid=9754521 | doi= | pmc=PMC1497021 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9754521  }} </ref><ref name="wiki">Fibroadenoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Fibroadenoma Accessed on January, 29 2016</ref>
Common risk factors in the development of fibroadenoma are [[obesity]], [[eostrogen replacement therapy]], and [[pregnancy|nulliparity]].<ref name="pmid9754521">{{cite journal| author=Greenberg R, Skornick Y, Kaplan O| title=Management of breast fibroadenomas. | journal=J Gen Intern Med | year= 1998 | volume= 13 | issue= 9 | pages= 640-5 | pmid=9754521 | doi= | pmc=PMC1497021 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9754521  }} </ref><ref name="wiki">Fibroadenoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Fibroadenoma Accessed on January, 29 2016</ref>
==Risk Factors==
==Risk Factors==
* The table below lists the risk factors involved in the development of fibroadenoma:<ref name="pmid9754521">{{cite journal| author=Greenberg R, Skornick Y, Kaplan O| title=Management of breast fibroadenomas. | journal=J Gen Intern Med | year= 1998 | volume= 13 | issue= 9 | pages= 640-5 | pmid=9754521 | doi= | pmc=PMC1497021 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9754521  }} </ref><ref name="wiki">Fibroadenoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Fibroadenoma Accessed on January, 29 2016</ref>
===Common Risk Factors===
 
*Common risk factors in the development of fibroadenoma include:
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px"
**Young age (<35 years)
|valign=top|
**Self breast examination
|+
**Prior history of benign breast disease
! style="background: #4479BA; width: 200px; color: #FFFFFF;"|'''Risk Factor'''
**Overweight females
 
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''Description'''
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Obesity]]'''|| style="padding: 5px 5px; background: #F5F5F5;" |An increase in [[BMI]] is correlated with an increased risk of fibroadenoma development.
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Estrogen]] replacement therapy'''|| style="padding: 5px 5px; background: #F5F5F5;" |[[Estrogen replacement therapy]] is correlated with an increased risk of fibroadenoma development.
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Pregnancy]]'''|| style="padding: 5px 5px; background: #F5F5F5;" |[[Pregnancy|Nulliparous]] women are associated with an increased risk of fibroadenoma development. Whereas [[Pregnancy|multiparous]] women are associated with a lower risk of fibroadenoma development.
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Contraception]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | The use of [[oral contraceptive pill]]s is associated with a lower risk of fibroadenoma development as compared to other contraceptive methods.
 
|-
 
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Socioeconomic status'''|| style="padding: 5px 5px; background: #F5F5F5;" |A higher socioeconomic status is correlated with an increased risk of fibroadenoma development.
|}


==References==
==References==

Revision as of 20:17, 14 January 2019

Fibroadenoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibroadenoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT Scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fibroadenoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibroadenoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroadenoma risk factors

CDC on Fibroadenoma risk factors

Fibroadenoma risk factors in the news

Blogs on Fibroadenoma risk factors

Directions to Hospitals Treating Fibroadenoma

Risk calculators and risk factors for Fibroadenoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Common risk factors in the development of fibroadenoma are obesity, eostrogen replacement therapy, and nulliparity.[1][2]

Risk Factors

Common Risk Factors

  • Common risk factors in the development of fibroadenoma include:
    • Young age (<35 years)
    • Self breast examination
    • Prior history of benign breast disease
    • Overweight females

References

  1. Greenberg R, Skornick Y, Kaplan O (1998). "Management of breast fibroadenomas". J Gen Intern Med. 13 (9): 640–5. PMC 1497021. PMID 9754521.
  2. Fibroadenoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Fibroadenoma Accessed on January, 29 2016

Template:WH Template:WS